Joel Clement was director of the Office of Policy Analysis

New Post Public Reply Private Reply Replies (0) Message Board
dw
216
Joel Clement was director of the Office of Policy Analysis at the U.S. Interior Department until last week. He is now a senior adviser at the department’s Office of Natural Resources Revenue.

I am not a member of the deep state. I am not big government.

I am a scientist, a policy expert, a civil servant and a worried citizen. Reluctantly, as of today, I am also a whistleblower on an administration that chooses silence over science.

Nearly seven years ago, I came to work for the Interior Department, where, among other things, I’ve helped endangered communities in Alaska prepare for and adapt to a changing climate. But on June 15, I was one of about 50 senior department employees who received letters informing us of involuntary reassignments. Citing a need to “improve talent development, mission delivery and collaboration,” the letter informed me that I was reassigned to an unrelated job in the accounting office that collects royalty checks from fossil fuel companies.
I am not an accountant — but you don’t have to be one to see that the administration’s excuse for a reassignment such as mine doesn’t add up. A few days after my reassignment, Interior Secretary Ryan Zinke testified before Congress that the department would use reassignments as part of its effort to eliminate employees; the only reasonable inference from that testimony is that he expects people to quit in response to undesirable transfers. Some of my colleagues are being relocated across the country, at taxpayer expense, to serve in equally ill-fitting jobs.


I believe I was retaliated against for speaking out publicly about the dangers that climate change poses to Alaska Native communities. During the months preceding my reassignment, I raised the issue with White House officials, senior Interior officials and the international community, most recently at a U.N. conference in June. It is clear to me that the administration was so uncomfortable with this work, and my disclosures, that I was reassigned with the intent to coerce me into leaving the federal government.

On Wednesday, I filed two forms — a complaint and a disclosure of information — with the U.S. Office of Special Counsel. I filed the disclosure because eliminating my role coordinating federal engagement and leaving my former position empty exacerbate the already significant threat to the health and the safety of certain Alaska Native communities. I filed the complaint because the Trump administration clearly retaliated against me for raising awareness of this danger. Our country values the safety of our citizens, and federal employees who disclose threats to health and safety are protected from reprisal by the Whistleblower Protection Act and Whistleblower Protection Enhancement Act.

Removing a civil servant from his area of expertise and putting him in a job where he’s not needed and his experience is not relevant is a colossal waste of taxpayer dollars. Much more distressing, though, is what this charade means for American livelihoods. The Alaska Native villages of Kivalina, Shishmaref and Shaktoolik are perilously close to melting into the Arctic Ocean. In a region that is warming twice as fast as the rest of the planet, the land upon which citizens’ homes and schools stand is newly vulnerable to storms, floods and waves. As permafrost melts and protective sea ice recedes, these Alaska Native villages are one superstorm from being washed away, displacing hundreds of Americans and potentially costing lives. The members of these communities could soon become refugees in their own country.


Alaska’s elected officials know climate change presents a real risk to these communities. Gov. Bill Walker (I) and Sen. Lisa Murkowski (R) have been sounding the alarm and scrambling for resources to help these villages. But to stave off a life-threatening situation, Alaska needs the help of a fully engaged federal government. Washington cannot turn its back.

While I have given small amounts to Democratic candidates in the past, I have no problem whatsoever working for a Republican administration. I believe that every president, regardless of party, has the right and responsibility to implement his policies. But that is not what is happening here. Putting citizens in harm’s way isn’t the president’s right. Silencing civil servants, stifling science, squandering taxpayer money and spurning communities in the face of imminent danger have never made America great.
Now that I have filed with the Office of Special Counsel, it is my hope that it will do a thorough investigation into the Interior Department’s actions. Our country protects those who seek to inform others about dangers to American lives. The threat to these Alaska Native communities is not theoretical. This is not a policy debate. Retaliation against me for those disclosures is unlawful.


Let’s be honest: The Trump administration didn’t think my years of science and policy experience were better suited to accounts receivable. It sidelined me in the hope that I would be quiet or quit. Born and raised in Maine, I was taught to work hard and speak truth to power. Trump and Zinke might kick me out of my office, but they can’t keep me from speaking out. They might refuse to respond to the reality of climate change, but their abuse of power cannot go unanswered.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mazu Culture Forum Unveils New Initiatives in China

Updated Category News Views 126

A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...

Continue Reading
Foxconn Spotlights AI Advancements at Tech Day 2026

Updated Category News Views 127

Foxconn's Bold Step into AI Infrastructure Foxconn, the tech giant that most folks recognize for its sheer prowess in electronics manufacturing, isn't just idling on past laurels. During the 7th annual Hon Hai Tech Day 2026, it was a showcase of fireworks that left attendees buzzing about the future of AI infrastructure and beyond. And when Foxconn says it's transforming,...

Continue Reading
Haunted Attraction Insights from the Queen of Haunts

Updated Category News Views 5

Admit it—everyone's got that one fear that sends shivers down their spine. Whether it's the slithering scales of a snake or the manic laughter of a clown, those phobias are what make haunted attractions such a hit for thrillseekers across the country. Amber Arnett-Bequeaith, the so-called Queen of Haunts, knows a thing or two about turning those fears into unforgettable...

Continue Reading
European Doctors Explore Chinese Aesthetic Innovations

Updated Category News Views 39

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Continue Reading
Gooru AI Unveils Platform to Scale Human Expertise

Updated Category News Views 67

A New Wave of AI-Powered Solutions Hot off the press, Gooru AI's recent shindig in the heart of Dallas aimed to showcase something they call 'Digital Goorus.' Now that might sound like a newage tech gimmick but peel back the layers and you find an ambitious attempt to let folks spread their smarts without having to be everywhere all at once. Imagine being able to crack...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 69

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 172

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
MediaGo Wins Big in France with Optimized Strategies

Updated Category News Views 75

MediaGo's Winning Edge in Advertising Shake the dust off your boots and get ready for a tale of triumph straight out of San Francisco. MediaGo, the top dog in global intelligent advertising platforms, just added a couple of shiny awards to its trophy case thanks to the prestigious Les Cas d'OR 2026 in France. And let me tell ya, these wins aren't just about some pretty...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 71

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 33

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Consumer Product Risks: Insights from Legal Experts

Updated Category News Views 131

Investigation into Defective Consumer Products The Law Offices of Jason Turchin is currently investigating various claims related to defective consumer products that can potentially harm individuals. These products include commonly used items such as space heaters and HVAC systems, as well as kitchen equipment like coffee makers and pressure cookers. Each of these items...

Continue Reading
Nauticos Takes Bold Steps Toward Uncovering Earhart's Mystery

Updated Category News Views 303

Nauticos Aims to Solve a Historic Mystery Nauticos, a leader in deep-sea exploration and historical research, has announced an exciting new expedition to locate Amelia Earhart's Lockheed Electra. This groundbreaking mission is fueled by proprietary data that pinpoints the likely resting place of the iconic aircraft. The research advances our understanding of where Earhart...

Continue Reading
Equitable Bank Achieves Historic $300 Million Deposit Note Success

Updated Category News Views 197

Equitable Bank Closes Impressive $300 Million Deposit Note Issuance Equitable Bank, Canada's Challenger Bank™, has successfully closed a monumental $300 million floating rate deposit note issuance. This remarkable achievement marks the tightest spread on record for deposit notes of a similar term issued by the bank. The overwhelming response from investors demonstrates...

Continue Reading
Exploring the Long-Term Gains of Sprouts Farmers Market Stock

Updated Category News Views 98

Understanding the Growth of Sprouts Farmers Market Stock Over the last decade, Sprouts Farmers Market (NASDAQ: SFM) has demonstrated remarkable growth, consistently surpassing market returns by an impressive 3.05% annually. With average annual returns reaching 14.93%, this company's performance is a topic of great interest among investors. Initial Investment Insights...

Continue Reading
Anticipating Royalty Pharma's First Quarter 2025 Financial Results

Updated Category News Views 119

Upcoming Financial Results Announcement Royalty Pharma plc (Nasdaq: RPRX) is gearing up to share its financial journey for the first quarter of 2025 on May 8, 2025. As one of the largest buyers of biopharmaceutical royalties, the firm is set to unveil its latest financial results early in the day, prior to the opening of U.S. markets. This announcement will give investors...

Continue Reading